Addressing the Challenges of HPV Vaccination and Prevention of HPV-related Cancers in Young and Older Adults

A continuing medical education activity provided by NAMCP and AAMCN

New Frontiers for Neuromuscular Blockade Use and Reversal: Addressing Challenges for Improved Clinical and Economic Outcomes is a two-part webinar series focusing on the latest developments and management of neuromuscular blockade use and reversal

This is Part 1 of the series on HPV vaccination and prevention of HPV-related cancers

This activity is an archive from the webinar held September 16, 2020

This activity is valid from October 1, 2020 to October 1, 2022

Instructions for CME/NCPD: Complete the pre-test, listen to the audio and view the slides, complete the post test, complete the evaluation form and hit submit. You will be asked to enter your name and email address on the pre-test, evaluation and post-test. If you close your internet browser without completing the post test, you will have ONE more opportunity to complete. A score of 70% must be achieved on the post test to receive continuing education credits. If you do not pass the post test after two attempts, you will not be eligible to try again. Once you complete the evaluation form and score 70% or higher on your post test, you will automatically be given your certificate.

To print or save your certificate, you will need to click on the “download” button and either print or save.


Audience: This activity is intended for healthcare professionals practicing in managed care environments.

This activity is supported by an educational grant from
Merck Sharp & Dohme Corp.

Human papillomavirus (HPV) infection is the most common sexually transmitted infection in the United States, as well as a cause of various types of cancer. An estimated 79 million people in the United States are infected with some type of HPV, and approximately 50% of new infections occur in individuals before the age of 24. Despite the availability of safe and effective vaccines, HPV vaccination coverage remains low. There are various reasons why the vaccination rates are low, including patients' and/or parents' lack of knowledge about HPV and their discomfort with talking to health care providers about sexual activity, affordability, among other reasons.

Upon completion of this activity, participants will be able to:

  • Identify perceived barriers by both healthcare providers and patients to HPV vaccination

  • Identify disparities and barriers to HPV-associated cancer prevention across different patient populations

  • Assess the efficacy, safety, and utility of HPV vaccination in children, adolescents, and adults

  • Examine strategies to overcome barriers that impede successful completion of the HPV vaccination series

  • Align current clinical practices with key HPV vaccination and cancer screening recommendations

Faculty: Amanda Dempsey, MD, PhD, MPH
Professor of Pediatrics
ACCORDS (Adult and Child Consortium for Health Outcomes Research and Delivery Science)
Research Director, Pediatric Hospital Medicine
University of Colorado Anschutz Medical Campus


Dr. Dempsey serves on an advisory board for Merck, Pfizer, and Sanofi Pasteur. Her presentation has been peer reviewed for any bias.
  Planning Committee:
Bill Williams, MD has no real or perceived financial relationships to disclose.
Jeremy Williams has no real or perceived financial relationships to disclose.
Jacqueline Cole, RN, MS, CMCN has no real or perceived financial relationships to disclose.

NAMCP and/or the presenter has copyright or has received permissions for use of materials provided in this activity.

Accreditation & Designation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association of Managed Care Physicians (NAMCP) and American Association of Managed Care Nurses (AAMCN). The National Association of Managed Care Physicians is accredited by the ACCME to provide continuing medical education for physicians.

NAMCP designates this enduring material for a maximum of 1 AMA PRA Category 1 credit(s)TM. Each
physician should claim credit commensurate with the extent of their participation in the activity.

The American Association of Managed Care Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

Nurses who complete this activity and achieve a passing score will receive 1 hour in nursing continuing professional development.

This activity has been approved by the American Board of Managed Care Nursing for 1.0 contact hours toward CMCN recertification requirements.

This activity is supported by an educational grant from
Merck Sharp & Dohme Corp.

NAMCP and/or this website does not provide medical advice, diagnosis or treatment. NAMCP does not endorse or imply endorsement of the content on any linked website. This website is to be used as an informational resource. With any health related concern, consult with your physician or healthcare professional.

Click Here To Continue